Literature DB >> 16901598

Alterations of muscarinic and GABA receptor binding in the posterior cingulate cortex in schizophrenia.

Kelly A Newell1, Katerina Zavitsanou, Stephen Kum Jew, Xu-Feng Huang.   

Abstract

The posterior cingulate cortex (PCC), a key component of the limbic system, has been implicated in the pathology of schizophrenia because of its sensitivity to NMDA receptor antagonists. Recent studies have shown that the PCC is dysfunctional in schizophrenia, and it is now suspected to be critically involved in the pathogenesis of schizophrenia. Studies also suggest that there are abnormalities in muscarinic and GABAergic neurotransmission in schizophrenia. Therefore, in the present study we used quantitative autoradiography to investigate the binding of [(3)H]pirenzepine, [(3)H]AF-DX 384 and [(3)H]muscimol, which respectively label M1/4 and M2/4 muscarinic and GABA(A) receptors, in the PCC of schizophrenia and control subjects matched for age and post-mortem interval. The present study found that [(3)H]pirenzepine binding was significantly decreased in the superficial (-24%, p=0.002) and deep (-35%, p<0.001) layers of the PCC in the schizophrenia group as compared with the control group. In contrast, a dramatic increase in [(3)H]muscimol binding was observed in the superficial (+112%, p=0.001) and deep layers (+100%, p=0.017) of the PCC in the schizophrenia group. No difference was observed for [(3)H]AF-DX 384 binding between the schizophrenia and control groups. The authors found a significant inverse correlation between [(3)H]pirenzepine binding in the deep cortical layers and [(3)H]muscimol binding in the superficial layers (rho=-0.732, p=0.003). In addition, negative correlations were also found between age and [(3)H]pirenzepine binding in both superficial and deep cortical layers (rho=-0.669 p=0.049 and rho=-0.778, p=0.014), and between age of schizophrenia onset and [(3)H]AF-DX 384 binding (rho=-0.798, p=0.018). These results for the first time demonstrated the status of M1/M4, M2/M4 and GABA(A) receptors in the PCC in schizophrenia. Whilst the exact mechanism causing these alterations is not yet known, a possible increased acetylcholine and down regulated GABA stimulation in the PCC of schizophrenia is suggested.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16901598     DOI: 10.1016/j.pnpbp.2006.07.004

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  28 in total

1.  Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia.

Authors:  Kelly A Newell; Chao Deng; Xu-Feng Huang
Journal:  Exp Brain Res       Date:  2006-05-19       Impact factor: 1.972

Review 2.  Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

Authors:  John E Lisman; Joseph T Coyle; Robert W Green; Daniel C Javitt; Francine M Benes; Stephan Heckers; Anthony A Grace
Journal:  Trends Neurosci       Date:  2008-04-07       Impact factor: 13.837

3.  Changes in BQCA Allosteric Modulation of [(3)H]NMS Binding to Human Cortex within Schizophrenia and by Divalent Cations.

Authors:  Brian Dean; Shaun Hopper; P Jeffrey Conn; Elizabeth Scarr
Journal:  Neuropsychopharmacology       Date:  2015-10-29       Impact factor: 7.853

4.  Effects of anticholinergic challenge on psychopathology and cognition in drug-free patients with schizophrenia and healthy volunteers.

Authors:  Tanja Veselinović; Ingo Vernaleken; Hildegard Janouschek; Thilo Kellermann; Michael Paulzen; Paul Cumming; Gerhard Gründer
Journal:  Psychopharmacology (Berl)       Date:  2014-11-07       Impact factor: 4.530

Review 5.  Neuroimaging biomarkers for early drug development in schizophrenia.

Authors:  Jason R Tregellas
Journal:  Biol Psychiatry       Date:  2013-10-04       Impact factor: 13.382

6.  Modulation of prepulse inhibition through both M(1) and M (4) muscarinic receptors in mice.

Authors:  Morgane Thomsen; Jürgen Wess; Brian S Fulton; Anders Fink-Jensen; S Barak Caine
Journal:  Psychopharmacology (Berl)       Date:  2009-12-15       Impact factor: 4.530

7.  Decreased white matter FA values in the left inferior frontal gyrus is a possible intermediate phenotype of schizophrenia: evidences from a novel group strategy.

Authors:  Jianjun Ou; Hailong Lyu; Maorong Hu; Jun Li; Wenbin Guo; Xiaofeng Guo; Lihua Li; Junjie Zheng; Qinling Wei; Feng Liu; Zhong He; Juan Wang; Fang Liu; Renrong Wu; Jindong Chen; Lehua Li; Bin Hu; Huafu Chen; Jingping Zhao
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-12-09       Impact factor: 5.270

8.  Altered brain long-range functional interactions underlying the link between aberrant self-experience and self-other relationship in first-episode schizophrenia.

Authors:  Sjoerd J H Ebisch; Dante Mantini; Georg Northoff; Anatolia Salone; Domenico De Berardis; Francesca Ferri; Filippo M Ferro; Massimo Di Giannantonio; Gian L Romani; Vittorio Gallese
Journal:  Schizophr Bull       Date:  2013-11-04       Impact factor: 9.306

9.  No changes in densities of cannabinoid receptors in the superior temporal gyrus in schizophrenia.

Authors:  Chao Deng; Mei Han; Xu-Feng Huang
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

Review 10.  A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia.

Authors:  Martin Sarter; Vicente Martinez; Rouba Kozak
Journal:  Psychopharmacology (Berl)       Date:  2008-07-10       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.